Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-21
2006-11-21
Campbell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S345000
Reexamination Certificate
active
07138371
ABSTRACT:
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group a peptide.
REFERENCES:
patent: 4055635 (1977-10-01), Green et al.
patent: 4088538 (1978-05-01), Schneider
patent: 4179337 (1979-12-01), Davis et al.
patent: 4412989 (1983-11-01), Iwashita et al.
patent: 4414147 (1983-11-01), Klibanov et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4925796 (1990-05-01), Bergh et al.
patent: 5154924 (1992-10-01), Friden
patent: 5182107 (1993-01-01), Friden
patent: 5352670 (1994-10-01), Venot
patent: 5374541 (1994-12-01), Wong
patent: 5405753 (1995-04-01), Brossmer
patent: 5432059 (1995-07-01), Bean
patent: 5492821 (1996-02-01), Callstrom et al.
patent: 5527527 (1996-06-01), Friden
patent: 5545553 (1996-08-01), Gotschlich
patent: 5621039 (1997-04-01), Hallahan et al.
patent: 5672683 (1997-09-01), Friden et al.
patent: 5716812 (1998-02-01), Withers et al.
patent: 5728554 (1998-03-01), Bayer et al.
patent: 5833988 (1998-11-01), Friden
patent: 5834251 (1998-11-01), Maras et al.
patent: 5876980 (1999-03-01), DeFrees et al.
patent: 5922577 (1999-07-01), Defrees et al.
patent: 5969040 (1999-10-01), Hallahan et al.
patent: 5977307 (1999-11-01), Friden
patent: 6015555 (2000-01-01), Friden
patent: 6030815 (2000-02-01), DeFrees et al.
patent: 6166183 (2000-12-01), Ishikawa et al.
patent: 6183738 (2001-02-01), Clark
patent: 6692931 (2004-02-01), Reutter et al.
patent: WO 87/00056 (1987-01-01), None
patent: WO 87/05330 (1987-09-01), None
patent: WO 89/10134 (1989-11-01), None
patent: WO 90/07572 (1990-07-01), None
patent: WO 92/18135 (1993-05-01), None
patent: WO 94/05332 (1994-03-01), None
patent: WO 94/15625 (1994-07-01), None
patent: WO 95/02421 (1995-01-01), None
patent: WO 96/40731 (1996-06-01), None
patent: WO 96/32491 (1996-10-01), None
patent: WO 98/31826 (1998-07-01), None
patent: WO 98/58964 (1998-12-01), None
patent: WO 99/00150 (1999-01-01), None
patent: WO 99/22764 (1999-05-01), None
patent: WO 01/49830 (2001-07-01), None
patent: WO 01/60411 (2001-08-01), None
patent: WO 02/02597 (2002-01-01), None
patent: WO 02/13843 (2002-02-01), None
patent: WO 02/13873 (2002-02-01), None
patent: WO 02/074806 (2002-09-01), None
Abuchowski et al. 1997, J. Biol. Chem. 252:3578-3581.
Berg-Fassman et al. 1993, J. Biol. Chem. 268:14861-14866.
Bhatia et al. 1989, Anal. Biochem. 178:408-413.
Bickel et al., 2001, Adv. Drug Deliv. Rev. 46:247-279.
Biome et al., 1999, Recent Prog. Horm. Res. 54:271-289.
Bishop et al., 1995, Endocrinology 136:2635-2640.
Butnev et al., 1998, Biology of Reproduction 58:458-469.
Casares et al., 2001, Nat. Biotechnol. 19:142-147.
Chaffee et al., 1992, J. Clin. Invest. 89:1643-1651.
Charter et al., 2000, Glycobiology 10:1049-1056.
Conradt et al., 1987, J. Biol. Chem. 262:14600-14605.
Eavarone, et al., 2000, J. Biomed. Mater. Res. 51:10-14.
Fibi et al., 1995, Cells Blood 85:1229-1236.
Fischer et al., 1998, Thrombosis Research 89:147-150.
Garnett 2002, Advanced Drug Delivery Reviews 53: 171-216.
Gillis et al., 1988, Behring Inst. Mitt. Aug. 83:1-7.
Hall 2001, Methods in Molecular Biology 166: 139-154.
Hilles et al. 2002, American Biotechnology Laboratory, 20:30.
Hang et al., 2001, J. Am. Chem. Soc. 123:1242-1243.
Hellström et al., 2001, Methods in Molecular Biology 166:3-16.
Ichikawa et al., 1992, J. Am. Chem. Soc. 114:9283-9298.
Inoue et al., 1995, Biotechnology Annual Review 1:297-313.
Katre et al., 1987 Proc. Natl. Acad. Sci. 84:1487-1491.
Kitamura et al., 1990, Biochem. Biophys. Res. Commun. 171:1387-1394.
Koeller et al., 2000, Nat. Biotechnol. 18:835-841.
Kreitman 2001, Current Pharmaceutical Biotechnology 2:313-325.
Lee et al., 1989, Biochemistry 28:1856-1861.
Li et al., 2002, Medicinal Research Reviews 22:225-250.
Li et al., 2002, Trends in Pharmacological Sciences 23:206-209.
Lui et al., 1996, Chem. Eur. J. 2:1359-1362.
Lord et al., 2001, Clin. Cancer Res. 7:2085-2090.
Mahal et al., 1997, Science 276:1125-1128.
Maras et al., 2000, Molecular cloning and enzymatic characterization of a Trichoderma reesei 1,2-α-D-mannosidase, 77:255-263.
Min et al., 1996, Endocr. J. 43:585-593.
Morimoto et al., 1996, Glycoconjugate J. 13:1013-1020.
Olson et al., 1999, J. Biol. Chem. 274:29889-29896.
Paulson et al., 1997, J. Biol. Chem. 252:8624-8628.
PEG Glucocerebrosidase, Internet page from www.gaucher.org.uk/peg2.prg, printed Jun. 21, 2002.
Pyatak et al., 1980, Res. Commun. Chem. Pathol. Pharmacol. 29:113-127.
Rambouille et al., 1999, J. Cell Biol. 112:3319-3330.
Reff et al., 2002, Cancer Control 9:152-166.
Saneyoshi et al., 2001, Biology of Reproduction 65:1686-1690.
Saxon et al., 2000, Science 287: 2007-2010.
Shah et al., 1996, J. Pharm. Sci. 85:1306-1311.
Singh et al., 1996, Chem. Commun. 1996:993-994.
Song et al., 2002, J. Pharmacol. Exp. Ther. 301:605-610.
Srinivasachar et al., 1989, Biochemistry 28:2501-2509.
Takane et al., 2000, J. Pharmacology and Experimental Therapeutics 294:746-752.
Tsuboi et al., 2000, Archives of Biochemistry and Biophysics 374:100-106.
Ulloa-Aguirre et al., 1999, Role of Glycosylation in Function of Follicle-Stimulating Hormone, Endocrine 11:205-215.
Uludag et al., 2002, Biotechnol. Prog. 18:604-611.
van Berkel et al., 1996, Biochem J. 319:117-122.
Vyas et al., 2001, Crit. Rev. Ther. Drug Carrier Syst. 18:1-76.
Wang et al., 1996, Tetrahedron Lett. 37:1975-1978.
Wellhoner et al., 1991, J. Biol. Chem. 226:4309-4314.
Wong et al., 1982, J. Org. Chem. 47:5416-5418.
Woods et al., 1989, Eur. J. Cell Biol. 50:132-143.
Wu et al., 2002, J. Drug Targeting 10:239-245.
Xing et al., 1998, Biochem. J. 336:667-673.
Yamamoto et al., 1997, Carbohydr. Res. 305:415-422.
Yarema et al., 1998, J. Biol. Chem. 47:31168-31179.
Bowe Caryn
DeFrees Shawn
Zopf David A.
Campbell Bruce R.
Heard Thomas S.
Neose Technologies, Inc
LandOfFree
Remodeling and glycoconjugation of peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Remodeling and glycoconjugation of peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remodeling and glycoconjugation of peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649641